Table 2.
Antimicrobial Agents | Number of Studies | Number of Isolates | % Prevalence (95% CI) | I2 (95% CI) |
---|---|---|---|---|
Tetracycline | 9 | 1192 | 67.4 | (53.8–78.6) |
Chloramphenicol | 8 | 243 | 2.6 | (14.6–28.2) |
Ciprofloxacin | 6 | 167 | 28.9 | (8.5–63.9) |
Sulphonamides | 3 | 285 | 92.0 | (37.5–99.5) |
Nalidixic acid | 3 | 144 | 39.8 | (22.3–60.5) |
Streptomycin | 9 | 593 | 37.7 | (17.2–63.8) |
Ampicillin | 13 | 900 | 38.6 | (25.4–53.7) |
Streptomycin | 9 | 593 | 37.7 | (17.2–63.8) |
Amoxicillin | 3 | 80 | 19.2 | (13.8–26.1) |
Trimethoprim | 3 | 477 | 52.2 | (24.7–78.4) |
Enrofloxacin | 6 | 20 | 89.3 | (62.9–97.6) |
Erythromycin | 6 | 954 | 89.3 | (62.9–97.6) |
Gentamicin | 6 | 95 | 15.4 | (7.0–3.5) |
Sulphamethoxazole | 3 | 165 | 39.5 | (32.6–46.8) |
kanamycin | 6 | 172 | 26.7 | (10.1–54.1) |
Imipenem | 3 | 517 | 72.6 | (23.1–95.9) |
Oxytetracycline | 4 | 382 | 77.4 | (31.2–96.3) |
Trimethoprim-sulfamthoxazole | 4 | 110 | 47.5 | (26.3–69.6) |
MDR | 5 | 314 | 28.5 | (11.2–55.7) |